Silo Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Silo Pharma generated cash of -$3,224,498, which is more than the previous year. Cash used in financing activities reached the amount of -$471,121 last year. Net change in cash is therefore -$7,842,726.
Cash Flow
| 2014 | -1.06M | -939.95K | 791.86K |
|---|---|---|---|
| 2015 | -1.01M | -875.40K | -2.25K |
| 2016 | -143.55K | 344.48K | 0 |
| 2017 | -284.61K | 157.56K | 0 |
| 2018 | 272.63K | -250K | 19.45K |
| 2019 | -794.32K | 186.74K | 382.65K |
| 2020 | -1.15M | 39K | 2.13M |
| 2021 | -2.27M | 7.19M | 3.79M |
| 2022 | -3.49M | 86.70K | 4.94M |
| 2023 | -3.22M | -4.14M | -471.12K |
SILO Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 11.36M | 9.83M | 1.12M | 111.75K | 336.67K | 294.59K | 579.20K | 722.76K | 1.73M | 2.01M |
Operating activities | ||||||||||
Net income | -3.70M | -3.90M | 3.90M | -3.03M | -1.01M | -969.46K | 356.53K | -1.11M | -409.49K | -376.54K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 90.06K | 0 | 107.97K | 578.92K | 61.87K | 17.55K | 0 | 0 | -8.14K | 219.95K |
Stock-based compensation expense | 104.19K | 156.04K | 191.69K | 1.18M | 177.96K | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 104.19K | 156.04K | 191.69K | 1.18M | 177.96K | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -4.8K | -1.21K | -72.52K | -29.23K | 0 | -20.36K | -44.77K | -11.29K | 0 |
Inventories | 0 | 4.8K | -24.96K | -15.06K | -129.39K | -26.97K | 0 | 0 | 0 | 0 |
Accounts payable | 339.27K | -53.72K | 291.05K | 72.52K | 29.23K | -12.71K | -14.75K | -37.65K | 88.20K | -1.16K |
Cash generated by operating activities | -3.22M | -3.49M | -2.27M | -1.15M | -794.32K | 272.63K | -284.61K | -143.55K | -1.01M | -1.06M |
Investing activities | ||||||||||
Purchases Of Investments | -4.14M | 0 | 0 | 0 | -5.19K | 0 | 0 | -330.72K | -1.30M | -1.46M |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -4.14M | 86.70K | 7.19M | 39K | 186.74K | -250K | 157.56K | 344.48K | -875.40K | -939.95K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 4.94M | 3.79M | 2.11M | 110K | 24.5K | 0 | 0 | 0 | 840K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.25K | 0 |
Repurchases of common stock | -471.12K | 0 | 0 | 0 | 0 | -2.87K | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -35K | 272.65K | -2.17K | 0 | 0 | 0 | -15K |
Cash used in financing activities | -471.12K | 4.94M | 3.79M | 2.13M | 382.65K | 19.45K | 0 | 0 | -2.25K | 791.86K |
Net Change In Cash | -7.84M | 1.53M | 8.70M | 1.01M | -224.92K | 42.08K | -284.61K | -143.55K | -1.01M | -271.1K |
Cash at end of period | 3.52M | 11.36M | 9.83M | 1.12M | 111.75K | 336.67K | 294.59K | 579.20K | 722.76K | 1.73M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |